Recent Headlines
Within Pharmaceuticals
Bioo Scientific Completes ISO 9001:2008 Recertification Process
Bioo Scientific has been recertified for another three years under the international ISO 9001:2008 standard (ISO CI#: SARA-2009-CA-0114-A). - January 21, 2016 - Bioo Scientific
Steve Cotter Releases Online Interactive Kettlebell Training
Steve Cotter, one of the world’s preeminent kettlebell instructors is pleased to announce the release of Steve Cotter’s Kettlebell University™. The Kettlebell University™ is a membership based, online, interactive training system for Members of all ages and fitness levels organized in 3 modules, Kettlebell Training, Nutrition, and The Science of Fitness. - January 20, 2016 - Steve Cotter's Kettlebell University™
Detectamet’s New Detectable Paper to Reduce Paper Contamination of Food
Paper in food processing is still essential for printed instructions, recording of process activities and making labels. Consumers hate paper in food. To reduce this contamination a Detectable Paper is now available from Detectamet. It is made using a patented combination of paper and film in a detectable and durable laminate and can be used in common printing systems. - January 20, 2016 - Detectamet
Microbiome Therapeutics Market: What’s the Future Potential?
The "Microbiome Therapeutics Market, 2015-2030" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. - January 18, 2016 - Roots Analysis
Dr. Cali Estes of The Addictions Academy Featured in the First Starter Kit to Recovery at Home
In a Program Series that is the first of its kind, Dr. Cali Estes has been featured in the Starter Kit to Recovery. The program is designed for those that can not afford traditional addiction treatment services. - January 17, 2016 - The Addictions Academy
Atomo Diagnostics Secures US$6M Investment from The Global Health Investment Fund
The Global Health Investment Fund (GHIF) announced today that it has provided a US$6 million [A$8.5 million] loan to Atomo Diagnostics (Atomo) to support scale-up of Atomo’s production operations and expansion of commercial activities related to the AtomoRapid™ rapid diagnostic test (RDT) platform. Funds will also be used to commercialise a self-test solution for HIV and other infectious diseases. - January 16, 2016 - Atomo Diagnostics
IQ4I Research & Consultancy Released a New Report on "3-Dimensional Cell Culture Global Market-Forecast to 2021"
The 3D cell culture global market is poised to grow at a double digit CAGR to reach $3,702.2 million by 2021. Rise in Research and Development Investments, rising need for organ transplantation, use of 3D cell culture models as an alternative tool for invivo testing, microfluidic technology and increasing focus on regenerative medicine are set to drive the market. - January 16, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
IQ4I Research & Consultancy Published a New Report on "Wound Closure and Advanced Wound Care Global Market" Estimated to be Worth $22.1 Billion by 2021
Wound closure and advanced wound care global market is expected to grow at single high digit CAGR to reach $22,126 million by 2021. - January 15, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Continental Disc Corporation and Groth Corporation Appoint BCE as Exclusive Northern California Representative
Continental Disc Corporation, a leading manufacturer of rupture disc technology, and Groth Corporation, a global leader in pressure relief, detonation and flame containment, announces that Belilove Company-Engineers (BCE), a manufacturers’ representative firm with over 65 years of process... - January 15, 2016 - Belilove Company-Engineers
Pancreatic Cancer-Pipeline Insights, 2016- A DelveInsight Report
DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients... - January 15, 2016 - DelveInsight
IQ4I Research & Consultancy Published a New Report on “Drug Discovery Outsourcing (DDO) Global Market”: Estimated to be Worth $29.0 Billion in 2022
IQ4I Research & Consultancy published a new report on “Drug Discovery Outsourcing (DDO) Global Market – Forecast To 2022” which analyzes and studies the major competition, market drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World, spread through 182 slide. - January 14, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Peripheral Lung Cancer-Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Peripheral Lung Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients... - January 14, 2016 - DelveInsight
Drug Safety Company Expands Operations
Drug Safety Navigator, LLC (DSN) Announces Another Expansion in Its Fifth Year of Operation - January 13, 2016 - Drug Safety Navigator, LLC
Hula Health Making "Waves" in Health and Nutrition
Health Supplement Company Announces Launch. - January 13, 2016 - Hula Health
Novant Health to Detail Pharmacist-Driven Post-Discharge Drug Therapy Management Effort for High-Risk Patients in February 3, 2016 Webinar
A February 3, 2016 webinar will explore Novant Health's clinical pharmacist-driven medication management effort that identifies patients at high risk for readmissions or ED visits related to adverse drug events. - January 13, 2016 - Healthcare Intelligence Network
DelveInsight's Market Research Reports, 2016
DelveInsight has established its strong presence in therapeutic areas and has launched Analytical Reports on indication, mechanism of actions, drugs, Global API Manufacturers and specialized Reports on Gene Therapy, Anticoagulants, PD-1 and PDL-1, CART and Antibody Drug conjugates. After... - January 13, 2016 - DelveInsight
World Parkinson’s Program Strives to Improve Parkinson’s Care Around the Globe
World Parkinson's Program held its annual seminar in Toronto, Canada. The seminar was attended by both patients and healthcare professionals to discuss the situation faced by Parkinson's patients around the world. The focus was on patients in underdeveloped countries who cannot afford medications, walkers or canes. - January 12, 2016 - World Parkinson's Program
BÜHLMANN Laboratories Opens North American Affiliate
BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - January 11, 2016 - BUHLMANN Diagnostics Corp
LSBU Accredits First Online Postgraduate Qualifications in Obesity Care and Management
London South Bank University (LSBU) has accredited three innovative new online courses in Obesity Care and Management, including the UK’s first completely online Masters degree in the field. The courses are being delivered by the College of Contemporary Health (CCH), which has been pioneering... - January 11, 2016 - College of Contemporary Health
Parkinson’s Patients in India Need More Resources, World Parkinson’s Program Emphasizes
A Canadian based non-profit organization, World Parkinson’s Program, held a seminar in Delhi, India to lecture about Parkinson’s disease. The lectures included multiple topics, and included a question and answer period. Those who attended included physicians, neurologists and other healthcare professionals from India. - January 10, 2016 - World Parkinson's Program
NanoHybrids Receives Grant Funding to Develop Breakthrough Technology in Cancer Detection and Diagnosis
NanoHybrids receives $225,000 from the National Cancer Institute (NCI) to develop breakthrough immunohistochemistry (IHC) technology. - January 10, 2016 - NanoHybrids
Largest U.S. Sponsor of Medicare ACOs to Share Data Analytics Tactics for Accountable Care During January 27, 2016 Webinar
Collaborative Health Systems, the nation's largest sponsor of Medicare Shared Savings ACOs, will share how data analytics has improved accountable care results during a January 27, 2016 webinar sponsored by the Healthcare Intelligence Network. - January 07, 2016 - Healthcare Intelligence Network
Rx Partnership Receives $10,000 Critical Community Needs Grant from Dominion to Support Medication Access at Northern Neck Free Health Clinic
Grant will be used to provide the equivalent of $14.3M in prescription medications. - January 07, 2016 - Rx Partnership
Now More Hope for Menopausal Women Experiencing the Physical and Emotional Impact of Painful Sex and Vaginal Dryness
New clinical data released on Prasterone (DHEA) Vaginal Ovules' positive effect on moderate to severe dyspareunia (Painful sex due to menopause) and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. - January 06, 2016 - Endoceutics
SAPA and Beijing CFDA Delegation Held Workshop Successfully on Regulatory Landscape in China and US
On December 21, 2015, Sino-American Pharmaceutical Professionals Association (SAPA) hosted an 18-person delegation from Beijing Food and Drug Administration (Beijing CFDA) at the New Jersey Commercialization Center for Innovative Technology, located in North Brunswick, NJ. - January 06, 2016 - Sino-American Pharmaceutical Professionals Association
New Supplement Company Focuses on Successful Middle-Aged Men
A new supplement company called Silver Wolf Nutrition is being launched in 2016 to provide successful, middle-aged men with specific solutions to help them increase their longevity. The company did extensive research to produce a line of supplements that solve the specific issues that educated men aged 35 to 55 years old face on a regular basis. This includes natural remedies for enhanced workout energy, focus, sleep, muscle development and retention, and more. - January 06, 2016 - Silver Wolf Nutrition
Rx Partnership Awarded Grant from the Mary Washington Hospital to Support Medication Access at Lloyd F. Moss Free Clinic
The clinic has accessed more than $23.9 million worth of free medication and assisted over 6,200 patients with the help of nonprofit Rx Partnership and the financial support of the Mary Washington Hospital and other funders. - January 06, 2016 - Rx Partnership
January 26 Webinar to Examine Physician Reimbursement in 2016: Workflow Optimization for Chronic Care Management and Advance Care Planning
Bon Secours Medical Group will describe its approach to chronic care management reimbursement and positioning for billable advance care planning in 2016 during a January 26, 2016 webinar sponsored by the Healthcare Intelligence Network. - January 05, 2016 - Healthcare Intelligence Network
Negotiations Are Finished. EU General Data Protection Regulation is Coming. Prepare Yourself Now.
After four years of intense wrangling for a uniform level of data protection in Europe, binding for each Member State, the chief negotiators of the European Parliament, the EU Commission, and the Council of Ministers came to an agreement on 12/15/2015 on the exact wording of the EU General Data Protection Regulation. The law firm of Kazemi & Lennartz Rechtsanwälte PartG is offering a range of training opportunities to companies already dealing with the new regulations at this time. - January 03, 2016 - Kazemi & Lennartz Rechtsanwälte PartG
Speaking of NEC Podcast Featuring Dr. Sergio Golombek Recently Launches
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - January 01, 2016 - The Morgan Leary Vaughan Fund, Inc.
H2Biologics Licenses Worldwide, Exclusive Rights to Develop SD1-Granzyme B Drug Conjugate for Treatment of Mesothelin-Expressing Tumors
H2Biologics announced that it has been granted a worldwide, exclusive license by the Research Development Foundation (RDF) for the use of human granzyme B (GrB), a naturally occurring serine protease, in developing an immunoconjugate with a human single domain antibody (SD1) that targets... - December 31, 2015 - H2Biologics Inc.
Arlington Free Clinic Hosts Senator Adam Ebbin and Rx Partnership Board of Directors
State Senator Adam Ebbin (D-30th) and Rx Partnership’s Board of Directors toured the Arlington Free Clinic (AFC) on December 4 during the board’s quarterly meeting. Senator Ebbin and board members were able to learn about the clinic’s daily operations, challenges the clinic faces... - December 30, 2015 - Rx Partnership
RFID and Enhanced UDI Tracking Updates Announced by Matrix IT, Medical Tracking Systems
Matrix IT, Medical Tracking Systems has announced the addition of RFID data capture and product enhancements to TRACTUS, the world's first sterile field UDI scanning and compliance platform. The platform now also integrates with any health or inventory management system in a hospital. - December 30, 2015 - Matrix Medical Tracking Systems
World Parkinson’s Program Provides Quad Canes and Educational Material to Support Parkinson’s Patients in Kenya
World Parkinson's Program announces the continuation of its' "Fall Prevention Campaign" by delivering educational material to Africa Parkinson's Association. The material will aid those who suffer from Parkinson's disease and would not be able to afford healthcare supplies otherwise. - December 19, 2015 - World Parkinson's Program
National Brain Tumor Society Opens New Funding Call for Its Oligodendroglioma Research Fund
Request for Applications seeks proposals for research on clinically relevant biomarkers for oligodendroglioma tumors, closes January 15, 2016. - December 18, 2015 - National Brain Tumor Society
MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National... - December 17, 2015 - MiTeGen, LLC
VIRUN NutraBIOsciences Collaborates with Otwo Biotech Shenzhen; 6 New Patent Applications in 2015; Virun’s New Facility is High-Tech; New Webinar Takes a Look Inside
VIRUN continues its’ interstellar growth by working with Chinese company Otwo Biotech of Shenzhen to bring new highly concentrated EPA DHA Omega products to market. Six new patent applications added to an already robust holdings. Virun’s new facility in Pomona, CA. nears completion and boasts State of the Art, eco-friendly functionalism, that includes heightened spray drying capabilities. A Live, upcoming Webinar, Feb. 2016, showcasing an "Inside Look" into VIRUN manufacturing and R&D. - December 16, 2015 - VIRUN
2016 Healthcare Trends: Population Health Prevails in Pay-for-Value Realm
Population health management remains the most influential factor in healthcare business operations for the second consecutive year, according to a complimentary trends snapshot by the Healthcare Intelligence Network (HIN). - December 15, 2015 - Healthcare Intelligence Network
Hemophilia Treatment ACE910 Bypasses Factor VIII Inhibitor in Affinity Biologicals Plasmas
Chugai Pharmaceutical's newly developed antibody ACE910 is a potential lifesaving treatment for Hemophilia A patients who have developed Factor VIII inhibitors. A first-in-human study (1) recently published by the American Society of Hematology indicates that ACE910 may be a safe and effective treatment for hemophilia A patients. - December 11, 2015 - Affinity Biologicals
Research Square Announces Video Summaries Solution to Help Researchers Communicate Their Work More Effectively
Research Square is partnering with MyScienceWork to offer engaging Video Summaries of research through the Polaris platform for universities and institutions. - December 11, 2015 - Research Square
World Parkinson’s Program Refugees Initiative
World Parkinson’s Program announces the launch of a series of educational campaigns for raising awareness of Parkinson’s disease and dementia in Syrian refugees arriving to Canada. “In the special Syrian refugee clinics set up by Canadian physicians, World Parkinson’s... - December 10, 2015 - World Parkinson's Program
Recursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. - December 08, 2015 - Recursion Pharmaceuticals
NuvOx Pharma Receives FDA Orphan Drug Designation for Radiosensitizer for Glioblastoma
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-108 for treatment of Glioblastoma. Orphan status provides NuvOx with development and commercial incentives such as tax credits for qualified clinical testing and market exclusivity for 7 years after the marketing approval is granted. - December 07, 2015 - NuvOx Therapeutics
ImaBiotech’s Multimaging™ Technology Chosen by Dermira for Its Skin Disposition Study
ImaBiotech today announced that Dermira, Inc., a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients, chose ImaBiotech’s Multimaging technology for a skin disposition study in Yorkshire pigs. Dermira presented the... - December 07, 2015 - Imabiotech
Saint-Gobain Seals Installs New Automation Machine That Manufactures OmniSeal® Spring-Energized Seals
Saint-Gobain Seals installs new automation machine at Willich, Germany site, which forms and assembles OmniSeal® spring-energized seals. Adding this new equipment not only allows the business to assemble the product in large quantities but also maintain their high standard of world class manufacturing and quality. - December 04, 2015 - Saint-Gobain Performance Plastics, Seals Group
Speaking of NEC Podcast Featuring Neonatal Ergonomics Expert Yamile Jackson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts-neonatologists, clinicians and researchers-that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - December 03, 2015 - The Morgan Leary Vaughan Fund, Inc.
F2G Ltd Announces the Acceptance of F901318 to Participate in the EMA’s Adaptive Pathways Pilot Programme
F2G Ltd, a UK based antifungal drug discovery and development company, today announced that its novel systemic antifungal product F901318 has been accepted to participate in the European Medicines Agency’s (EMA) Adaptive Pathways pilot programme. Initiated in March 2014, the Adaptive... - December 03, 2015 - F2G Ltd
IQ4I Research & Consultancy Published a New Report on “Neuromodulation Devices Global Market": Estimated to be Worth $9.3 Billion by 2021
Neuromodulation device market represents therapies specifically designed to deliver electrical current through internally implanted or externally stimulating devices to bring about desired change in nervous system. - December 03, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
Detectamet Tags Protect Critical Data from Shock Destruction
How do you identify and trace food batches passing through your process? Detectamet detectable processing ID tags reduce the risk of lost data. They will survive high/low temperature parameters and ensure ID traceability and data correlation. They reduce the risk of food product contamination because they are metal detectable. - December 03, 2015 - Detectamet
Global IoT Security Market is Expected to Reach USD 464 Million in 2020
IoT Security Market for Utilities, Automotive, Healthcare and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2020. - December 01, 2015 - Market Research Store